<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(12)</volume><submitter>Dal-Re R</submitter><pubmed_abstract>Rafael Dal-Ré and colleagues argue that the recruitment targets and performance of all site investigators in multi-centre clinical trials should be disclosed in trial registration sites before a trial starts, and when it ends.</pubmed_abstract><journal>PLoS medicine</journal><pagination>e1001149</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3246429</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Disclosure of investigators' recruitment performance in multicenter clinical trials: a further step for research transparency.</pubmed_title><pmcid>PMC3246429</pmcid><pubmed_authors>Treweek S</pubmed_authors><pubmed_authors>Carne X</pubmed_authors><pubmed_authors>Moher D</pubmed_authors><pubmed_authors>Demotes-Mainard J</pubmed_authors><pubmed_authors>Dal-Re R</pubmed_authors><pubmed_authors>Gluud C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Disclosure of investigators' recruitment performance in multicenter clinical trials: a further step for research transparency.</name><description>Rafael Dal-Ré and colleagues argue that the recruitment targets and performance of all site investigators in multi-centre clinical trials should be disclosed in trial registration sites before a trial starts, and when it ends.</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Dec</publication><modification>2021-02-20T03:45:00Z</modification><creation>2019-03-27T00:47:23Z</creation></dates><accession>S-EPMC3246429</accession><cross_references><pubmed>22215987</pubmed><doi>10.1371/journal.pmed.1001149</doi></cross_references></HashMap>